サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1786584

ファティリティ・ツーリズムの世界市場

Fertility Tourism

出版日
ページ情報
英文 287 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
ファティリティ・ツーリズムの世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 287 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ファティリティ・ツーリズムの世界市場は2030年までに53億米ドルに達する見込み

2024年に15億米ドルと推定されるファティリティ・ツーリズムの世界市場は、2024年から2030年にかけてCAGR 23.1％で成長し、2030年には53億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるドナー卵子治療は、CAGR 26.5%を記録し、分析期間終了時には21億米ドルに達すると予測されます。自己卵子治療による体外受精（IVF With Own Egg Treatment）セグメントの成長率は、分析期間中CAGR 22.3％と推定されます。

米国市場は4億1,500万米ドルと推定、中国はCAGR 31.2％で成長すると予測

米国のファティリティ・ツーリズム市場は、2024年に4億1,500万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに13億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは31.2％となります。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ18.2%と20.9%と予測されています。欧州では、ドイツがCAGR約19.5%で成長すると予測されています。

世界のファティリティ・ツーリズム市場- 主要動向と促進要因のまとめ

なぜファティリティ・ツーリズムは生殖希望の国境を越えたライフラインとして台頭しているのか？

体外受精、卵子提供、代理出産、精子提供などの生殖補助医療（ART）を求めて、個人やカップルが海外に渡航することで、ファティリティ・ツーリズム（生殖医療または国境を越えた生殖医療とも呼ばれる）は大きな成長を遂げています。費用、利用可能性、法的枠組み、成功率の格差に後押しされ、この世界の動きは、ヘルスケアへのアクセスと海外旅行を融合させたメディカル・ツーリズムのサブセクターの隆盛を生み出しています。商業的代理出産の禁止、年齢や婚姻関係の制限、LGBTQ+の家族形成に対する制約など、自国での規制のために、より寛容な旅行先で治療を受けざるを得なくなり、ファティリティ・ツーリズムを利用する人が多いです。インド、ウクライナ、スペイン、ギリシャ、メキシコ、米国といった国々が、包括的で比較的安価な不妊治療サービスを提供する重要な拠点として台頭し、西欧、北米、中東、アジアから患者を集めています。感情的、経済的なリスクは高く、質の高い医療と慎重さ、待ち時間の短縮、法的保護を組み合わせることができるため、ファティリティ・ツーリズムは世界のリプロダクティブ・ヘルス事情においてますます求められるソリューションとなっています。

ファティリティ・ツーリズムのホットスポットを形成する法的・倫理的状況は？

法的フレームワークと倫理的配慮は、世界のファティリティ・ツーリズムエコシステムの中心であり、しばしば患者が治療のために旅行する場所を決定します。匿名での卵子・精子提供、妊娠中の代理出産、医療目的以外での胚凍結など、リベラルなART規制を持つ国は、海外からの患者にとって最重要な選択肢となりつつあります。例えば、スペインとチェコ共和国は、法的な匿名性とドナーの入手可能性により、ドナー卵子体外受精に好まれており、メキシコとコロンビアは、手頃な代理出産の選択肢と患者に優しい法律で人気を集めています。一方、ドイツ、フランス、中国、中東の一部などでは、規制が厳しい、あるいは規制が発展しつつあるため、個人は海外にサービスを求めるようになっています。特に商業的代理出産、搾取、インフォームド・コンセントに関する倫理的な懸念は、インドやタイのような国々での改革を促し、外国人に対するいくつかのサービスの閉鎖や、より厳しい監視の導入につながっています。このような法制度の変化は、不妊治療クリニックや代理店にとって、コンプライアンス、国境を越えた親権の法的承認、代理母やドナーの倫理的扱いなどの課題と機会の両方を生み出しています。不妊治療の行き先を選択する際、患者は価格の安さだけでなく、法的な明確さ、医療水準、倫理的なセーフガードを優先する傾向がますます強まっています。

人口動態、社会的規範、そしてアクセスのしやすさは市場拡大においてどのような役割を果たしているのか？

社会規範の変化、人口動態の動向、生殖に関する課題は、ファティリティ・ツーリズムに対する世界の需要に拍車をかけています。ライフスタイル要因、出産の遅れ、環境の影響、慢性疾患の割合の上昇などに起因する不妊率の上昇は、国境を越えて生殖医療を模索する個人を促しています。一方、同性カップル、選択による片親、親になることを望む高齢者など、従来とは異なる家族形態が受け入れられつつあり、ARTサービスの需要基盤が拡大しています。こうした患者グループの多くは、自国では法的または制度的な障壁に直面しているため、不妊治療を行いやすい国がより魅力的になっています。医療ツーリストのための合理化されたビザプロセス、多言語不妊治療コーディネーター、バンドルされた治療パッケージなどのアクセシビリティの向上も、物流上の障害を取り除いています。遠隔医療、遠隔診察、デジタル不妊モニタリングアプリの技術的進歩は、患者が遠くからペイシェントジャーニーを始めるのを助け、最初の障壁を減らし、透明性を高めています。さらに、ソーシャルメディア、オンラインフォーラム、不妊治療インフルエンサーは、世界の選択肢についての認識を高め、ピアツーピアの学習と証言主導の意思決定を可能にしています。生殖への願望がますます国境を越えるようになるにつれ、こうした社会的・人口統計学的なシフトは、ファティリティ・ツーリズムを個人的な解決策であると同時に成長する世界的産業として確立しつつあります。

世界のファティリティ・ツーリズム市場の成長促進要因とは？

ファティリティ・ツーリズム市場の成長は、医療の世界化、コスト格差、人口動態の変化、国境を越えた法的乖離に根ざしたいくつかの要因によって牽引されています。インド、ウクライナ、グルジアのような国々での体外受精や代理出産は、旅費や宿泊費を考慮しても、米国や英国より最大70％安価です。同時に、カナダや英国のような国々の公的医療制度では、ARTサービスの待ち時間が長いため、患者は海外により早くアクセスすることを求めています。医療ツーリズムに対する政府の戦略的支援に加え、渡航先国におけるART法の自由化も、インフラや国際的な患者サービスの改善を通じて成長に寄与しています。不妊症患者の増加、特に都市部の人口増加により、患者層が拡大する一方、不妊治療ラボの技術標準化により、評判の高い国際的なクリニックで一貫した成功率が保証されています。さらに、不妊治療代理店、コンシェルジュ・サービス、国際代理出産ネットワークの存在感が高まっており、渡航、法的契約、治療後のケアなど、エンド・ツー・エンドの調整がスムーズに行われるようになっています。最後に、擁護団体、インフルエンサー、セレブリティに支えられた生殖に関する課題に対するオープンな姿勢の高まりは、ARTのスティグマを取り除き、国境を越えた需要の急増を生み出し、ファティリティ・ツーリズムが生殖ヘルスケアの未来において不可欠なソリューションとしての地位を強化しています。

セグメント

治療（ドナー卵子治療、自己卵子による体外受精治療、代理出産治療、ドナー胚治療、精子提供治療）;年齢層（18-24, 25-34, 35-44, 45-54）

調査対象企業の例

  • Bangkok Hospital
  • Barbados Fertility Centre
  • BioTexCom Center for Human Reproduction
  • Bourn Hall Clinic
  • Clinica Tambre
  • Copenhagen Fertility Center
  • Dunya IVF Clinic
  • Embryolab Fertility Clinic
  • Fertility Associates
  • Fertility Center Mexico
  • Fertility First
  • GREFI（Grupo de Fertilidad y Ginecologia）
  • IVI Fertility
  • Life Clinic Athens
  • Medfem Fertility Clinic
  • NewLife IVF
  • North Cyprus IVF Centre
  • Nova IVF Fertility
  • Reprofit International
  • Sanatorium HELIOS

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールで市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP30924

Global Fertility Tourism Market to Reach US$5.3 Billion by 2030

The global market for Fertility Tourism estimated at US$1.5 Billion in the year 2024, is expected to reach US$5.3 Billion by 2030, growing at a CAGR of 23.1% over the analysis period 2024-2030. Donor Egg Treatment, one of the segments analyzed in the report, is expected to record a 26.5% CAGR and reach US$2.1 Billion by the end of the analysis period. Growth in the IVF With Own Egg Treatment segment is estimated at 22.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$415.0 Million While China is Forecast to Grow at 31.2% CAGR

The Fertility Tourism market in the U.S. is estimated at US$415.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 31.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.2% and 20.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 19.5% CAGR.

Global Fertility Tourism Market - Key Trends & Drivers Summarized

Why Is Fertility Tourism Emerging as a Cross-Border Lifeline for Reproductive Hope?

Fertility tourism-also known as reproductive or cross-border reproductive care-is witnessing significant growth as individuals and couples travel abroad in pursuit of assisted reproductive technologies (ART) like IVF, egg donation, surrogacy, and sperm donation. Driven by disparities in cost, availability, legal frameworks, and success rates, this global movement is giving rise to a thriving medical tourism sub-sector that blends healthcare access with international travel. Many turn to fertility tourism due to restrictive regulations in their home countries-such as bans on commercial surrogacy, age or marital status limits, or constraints on LGBTQ+ family-building-compelling them to seek treatment in more permissive destinations. Countries like India, Ukraine, Spain, Greece, Mexico, and the United States have emerged as key hubs offering comprehensive and comparatively affordable fertility services, attracting patients from Western Europe, North America, the Middle East, and Asia. The emotional and financial stakes are high, and the ability to combine high-quality medical care with discretion, reduced waiting times, and legal protection has made fertility tourism an increasingly sought-after solution in the global reproductive health landscape.

How Are Legal and Ethical Landscapes Shaping Fertility Tourism Hotspots?

Legal frameworks and ethical considerations are central to the global fertility tourism ecosystem, often determining where patients choose to travel for treatment. Countries with liberal ART regulations-allowing procedures like anonymous egg/sperm donation, gestational surrogacy, and embryo freezing for non-medical reasons-are becoming top choices for international patients. For instance, Spain and the Czech Republic are preferred for donor egg IVF due to legal anonymity and donor availability, while Mexico and Colombia have gained traction for affordable surrogacy options and patient-friendly laws. Meanwhile, restrictive or evolving regulations in countries like Germany, France, China, and parts of the Middle East are pushing individuals to seek services abroad. Ethical concerns-especially around commercial surrogacy, exploitation, and informed consent-have prompted reforms in countries like India and Thailand, leading to the closure of some services to foreigners or the introduction of stricter oversight. These shifting legal terrains create both challenges and opportunities for fertility clinics and agencies, who must navigate compliance, cross-border legal recognition of parental rights, and the ethical treatment of surrogates and donors. Increasingly, patients are prioritizing not just affordability, but also legal clarity, medical standards, and ethical safeguards when choosing a destination for fertility care.

What Role Are Demographics, Social Norms, and Accessibility Playing in Market Expansion?

Changing social norms, demographic trends, and reproductive challenges are fueling global demand for fertility tourism. The rise in infertility rates-driven by lifestyle factors, delayed childbearing, environmental influences, and rising rates of chronic conditions-is prompting individuals to explore reproductive care across borders. Meanwhile, growing acceptance of non-traditional family structures, including same-sex couples, single parents by choice, and older individuals seeking parenthood, is widening the demand base for ART services. Many of these patient groups face legal or institutional barriers in their home countries, making fertility-friendly nations more attractive. Accessibility improvements, such as streamlined visa processes for medical tourists, multilingual fertility coordinators, and bundled treatment packages, are also removing logistical obstacles. Technological advancements in telehealth, remote consultations, and digital fertility monitoring apps are helping patients begin their journey from afar, reducing initial barriers and enhancing transparency. Furthermore, social media, online forums, and fertility influencers are increasing awareness about global options, enabling peer-to-peer learning and testimonial-driven decision-making. As reproductive aspirations increasingly transcend borders, these social and demographic shifts are establishing fertility tourism as both a personal solution and a growing global industry.

What Are the Core Growth Drivers Accelerating the Fertility Tourism Market Globally?

The growth in the Fertility Tourism market is driven by several factors rooted in medical globalization, cost differentials, demographic shifts, and legal divergence across borders. One of the primary drivers is the significant variation in treatment costs-IVF and surrogacy procedures in countries like India, Ukraine, and Georgia can be up to 70% less expensive than in the U.S. or U.K., even after accounting for travel and accommodation. At the same time, long waiting periods for ART services in public healthcare systems across countries like Canada and the U.K. are prompting patients to seek faster access abroad. The liberalization of ART laws in destination countries, alongside strategic government support for medical tourism, is also contributing to growth by improving infrastructure and international patient services. Rising infertility prevalence, particularly in urban populations, is expanding the patient pool, while technological standardization in fertility labs ensures consistent success rates across reputable international clinics. Additionally, the growing presence of fertility agencies, concierge services, and international surrogacy networks is facilitating smoother end-to-end coordination of travel, legal contracts, and post-treatment care. Finally, increased openness around reproductive challenges-supported by advocacy groups, influencers, and celebrities-has de-stigmatized ART and created a demand surge that crosses national borders, reinforcing fertility tourism’s status as a vital solution in the future of reproductive healthcare.

SCOPE OF STUDY:

The report analyzes the Fertility Tourism market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment, Sperm Donation Treatment); Age Group (18-24, 25-34, 35-44, 45-54)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Bangkok Hospital
  • Barbados Fertility Centre
  • BioTexCom Center for Human Reproduction
  • Bourn Hall Clinic
  • Clinica Tambre
  • Copenhagen Fertility Center
  • Dunya IVF Clinic
  • Embryolab Fertility Clinic
  • Fertility Associates
  • Fertility Center Mexico
  • Fertility First
  • GREFI (Grupo de Fertilidad y Ginecologia)
  • IVI Fertility
  • Life Clinic Athens
  • Medfem Fertility Clinic
  • NewLife IVF
  • North Cyprus IVF Centre
  • Nova IVF Fertility
  • Reprofit International
  • Sanatorium HELIOS

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Fertility Tourism - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • High Cost of Fertility Treatments in Developed Nations Throws the Spotlight on Cross-Border Reproductive Options
    • Long Wait Times and Access Barriers Spur Demand for Affordable and Timely Fertility Care Abroad
    • Expanding Legalization of Surrogacy and Egg Donation in Select Countries Strengthens the Business Case for Fertility Tourism
    • Favorable Government Policies and Medical Infrastructure in Destination Countries Propel Growth of Reproductive Travel
    • Growing Awareness Through Online Communities and Medical Tourism Platforms Drives Patient Mobility Across Borders
    • Increasing Demand for Donor Gametes and Advanced ART Techniques Generates Opportunities in Specialized Fertility Clinics Abroad
    • LGBTQ+ and Single Parent Family Planning Needs Expand the Addressable Market for Inclusive Fertility Tourism Services
    • Rising Infertility Rates and Delayed Parenthood Trends Sustain Global Demand for Accessible Reproductive Solutions
    • Global Accreditation and Quality Certifications Build Trust and Standardization Across Cross-Border Clinics
    • Cultural Acceptance and Language Support Services Enhance Patient Comfort in Foreign Treatment Destinations
    • Technological Advancements in Remote Fertility Consultations Drive Pre- and Post-Treatment Integration Across Geographies
    • Ethical and Legal Complexities Around Surrogacy and Embryo Transport Create Regulatory Hurdles but Also Push for Reform
    • Rising Interest in Egg Freezing and Fertility Preservation Fuels Medical Travel Among Career-Oriented Individuals
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Fertility Tourism Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Fertility Tourism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Fertility Tourism by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Fertility Tourism by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Donor Egg Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Donor Egg Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Donor Egg Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for IVF With Own Egg Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for IVF With Own Egg Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for IVF With Own Egg Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Surrogacy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Surrogacy Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Surrogacy Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Donor Embryo Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Donor Embryo Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Donor Embryo Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Sperm Donation Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Sperm Donation Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Sperm Donation Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for 18-24 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for 18-24 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for 18-24 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for 25-34 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for 25-34 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for 25-34 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for 35-44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for 35-44 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for 35-44 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for 45-54 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for 45-54 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for 45-54 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • JAPAN
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • CHINA
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • EUROPE
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Fertility Tourism by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Fertility Tourism by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Fertility Tourism by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • FRANCE
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • GERMANY
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Tourism by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Fertility Tourism by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Fertility Tourism by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • INDIA
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Fertility Tourism by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Fertility Tourism by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Fertility Tourism by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Fertility Tourism by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Fertility Tourism by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Fertility Tourism by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030
  • AFRICA
    • Fertility Tourism Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Fertility Tourism by Treatment - Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Fertility Tourism by Treatment - Percentage Breakdown of Value Sales for Donor Egg Treatment, IVF With Own Egg Treatment, Surrogacy Treatment, Donor Embryo Treatment and Sperm Donation Treatment for the Years 2015, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Fertility Tourism by Age Group - 18-24, 25-34, 35-44 and 45-54 Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Fertility Tourism by Age Group - Percentage Breakdown of Value Sales for 18-24, 25-34, 35-44 and 45-54 for the Years 2015, 2025 & 2030

IV. COMPETITION